Year All202420232022202120202019201820172016 UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates November 4, 2024 UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 September 24, 2024 UNITY Biotechnology to Participate in Upcoming Investor Conferences August 12, 2024 UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates August 6, 2024 UNITY Biotechnology Reports Granting of New Employment Inducement Award July 24, 2024 UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer July 22, 2024 UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates May 14, 2024 UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting April 25, 2024 UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME April 23, 2024 UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates April 15, 2024
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates November 4, 2024
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 September 24, 2024
UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates August 6, 2024
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates May 14, 2024
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME April 23, 2024
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates April 15, 2024